Related Tags >> R788 Rheumatoid Arthritis AstraZeneca Clinical Trial Results

Rigel Pharmaceuticals News

Most Popular Rigel Pharmaceuticals Story

On the Radar: Five high-value biotech stocks

July 27, 2010 — 7:11am ET

Our new On the Radar report returns with fresh insights from Simos Simeonidis, PhD, Rodman & Renshaw's senior biotech analyst, who highlights biotech stocks which he believes will be good value

Read more...

Rigel Pharmaceuticals Press Releases

Rigel Pharmaceuticals, Inc. (RIGL) Assumes Development Responsibility for Inhaled Asthma Therapy; Rigel Pharmaceuticals, Inc. (R
Rigel Earns Milestone Payments From AstraZeneca
Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LL
PRESS RELEASE: Merck Serono Exercises Option to Rigel's R763/AS703569 and Aurora Kinase Inhibitors in the Japanese Territory

Latest Headlines

On the Radar: Five high-value biotech stocks
July 27, 2010
Germany's 4SC misses mark in key RA drug trial, CEO keeps faith
June 9, 2011
Rigel raises $130M for PhII trial of asthma drug
May 27, 2011
Pfizer returns allergic asthma drug to Rigel
May 6, 2011
AZ pushes pedal to metal on PhIII oral RA blitzkrieg
September 29, 2010
AZ/Rigel RA drug hits PhIIb paydirt
September 23, 2010
Was Rigel's $1.2B RA deal over-hyped?
February 22, 2010
Rigel says it's nearing psoriasis pact
February 17, 2010
Rigel scores blockbuster $1.24B pact with AstraZeneca
February 16, 2010
Rigel RA drug flunks Phase II trial
July 24, 2009
Positive RA study sets stage for lucrative Rigel pact
July 9, 2009
Rigel slices staff as it waits for IIb data
February 3, 2009
Rigel shares sink on arthritis drug concerns
October 29, 2008

Paid Research Reports

More Research Reports >>